Centerra Gold Inc. Common Shares (CGAU)
Fast GrowerFairStock Score: 92/100 — HIGH CONVICTION
Key Financials
| Current Price | $17.11 |
| Market Cap | $3.8B |
| P/E Ratio | 5.52 |
| ROE | 33.69% |
| Dividend Yield | 1.32% |
| Sector | Basic Materials |
Strengths
- High return on equity of 31.4% demonstrating efficient capital deployment
- Conservative balance sheet with debt-to-equity of just 0.01, providing financial flexibility
- Healthy net profit margin of 13.9% showing consistent profitability
- Revenue growth of 32.8% demonstrates strong top-line momentum
- FairStock composite score of 92/100 places it in the top tier across value, quality, and momentum factors
AI Analysis
Centerra Gold Inc. Common Shares is a small-cap basic materials company valued at $3.8 billion. The business generates $1.4 billion in annual revenue with a 13.9% net margin. From a quality standpoint, Centerra shows healthy Altman Z-Score of 3.7 and strong 31% ROE. On valuation, the stock is deeply undervalued on a P/E basis at 6.6x, with a modest 27% margin of safety vs Graham Number. Growth dynamics show revenue growing at 32.8% and profit growth of 467.2%. The 1.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 92/100 reflects strong fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.
Bull Case
Centerra's 33% revenue growth trajectory could accelerate as it captures additional market share in the basic materials sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the basic materials space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer